Direct-conversion molecular breast imaging of invasive breast cancer: Imaging features, extent of invasive disease, and comparison between invasive ductal and lobular histology

Amy Lynn Conners, Katie N. Jones, Carrie B Hruska, Jennifer R. Geske, Judy C Boughey, Deborah Rhodes

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

OBJECTIVE. The purposes of this study were to compare the tumor appearance of invasive breast cancer on direct-conversion molecular breast imaging using a standardized lexicon and to determine how often direct-conversion molecular breast imaging identifies all known invasive tumor foci in the breast, and whether this differs for invasive ductal versus lobular histologic profiles. MATERIALS AND METHODS. Patients with prior invasive breast cancer and concurrent direct-conversion molecular breast imaging examinations were retrospectively reviewed. Blinded review of direct-conversion molecular breast imaging examinations was performed by one of two radiologists, according to a validated lexicon. Direct-conversion molecular breast imaging findings were matched with lesions described on the pathology report to exclude benign reasons for direct-conversion molecular breast imaging findings and to document direct-conversion molecular breast imaging-occult tumor foci. Associations between direct-conversion molecular breast imaging findings and tumor histologic profiles were examined using chi-square tests. RESULTS. In 286 patients, 390 invasive tumor foci were present in 294 breasts. A corresponding direct-conversion molecular breast imaging finding was present for 341 of 390 (87%) tumor foci described on the pathology report. Invasive ductal carcinoma (IDC) tumor foci were more likely to be a mass (40% IDC vs 15% invasive lobular carcinoma [ILC]; p <0.001) and to have marked intensity than were ILC foci (63% IDC vs 32% ILC; p <0.001). Direct-conversion molecular breast imaging correctly revealed all pathology-proven foci of invasive disease in 79.8% of cases and was more likely to do so for IDC than for ILC (86.1% vs 56.7%; p <0.0001). Overall, direct-conversion molecular breast imaging showed all known invasive foci in 249 of 286 (87%) patients. CONCLUSION. Direct-conversion molecular breast imaging features of invasive cancer, including lesion type and intensity, differ by histologic subtype. Direct-conversion molecular breast imaging is less likely to show all foci of ILC compared with IDC.

Original languageEnglish (US)
Pages (from-to)W374-W381
JournalAmerican Journal of Roentgenology
Volume205
Issue number3
DOIs
StatePublished - Sep 1 2015

Fingerprint

Molecular Imaging
Histology
Breast
Breast Neoplasms
Lobular Carcinoma
Ductal Carcinoma
Neoplasms
Pathology
Chi-Square Distribution

Keywords

  • Breast cancer
  • Invasive ductal carcinoma
  • Invasive lobular carcinoma
  • Molecular breast imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

@article{0f96a586f68a4aa9941f699bd8169e3d,
title = "Direct-conversion molecular breast imaging of invasive breast cancer: Imaging features, extent of invasive disease, and comparison between invasive ductal and lobular histology",
abstract = "OBJECTIVE. The purposes of this study were to compare the tumor appearance of invasive breast cancer on direct-conversion molecular breast imaging using a standardized lexicon and to determine how often direct-conversion molecular breast imaging identifies all known invasive tumor foci in the breast, and whether this differs for invasive ductal versus lobular histologic profiles. MATERIALS AND METHODS. Patients with prior invasive breast cancer and concurrent direct-conversion molecular breast imaging examinations were retrospectively reviewed. Blinded review of direct-conversion molecular breast imaging examinations was performed by one of two radiologists, according to a validated lexicon. Direct-conversion molecular breast imaging findings were matched with lesions described on the pathology report to exclude benign reasons for direct-conversion molecular breast imaging findings and to document direct-conversion molecular breast imaging-occult tumor foci. Associations between direct-conversion molecular breast imaging findings and tumor histologic profiles were examined using chi-square tests. RESULTS. In 286 patients, 390 invasive tumor foci were present in 294 breasts. A corresponding direct-conversion molecular breast imaging finding was present for 341 of 390 (87{\%}) tumor foci described on the pathology report. Invasive ductal carcinoma (IDC) tumor foci were more likely to be a mass (40{\%} IDC vs 15{\%} invasive lobular carcinoma [ILC]; p <0.001) and to have marked intensity than were ILC foci (63{\%} IDC vs 32{\%} ILC; p <0.001). Direct-conversion molecular breast imaging correctly revealed all pathology-proven foci of invasive disease in 79.8{\%} of cases and was more likely to do so for IDC than for ILC (86.1{\%} vs 56.7{\%}; p <0.0001). Overall, direct-conversion molecular breast imaging showed all known invasive foci in 249 of 286 (87{\%}) patients. CONCLUSION. Direct-conversion molecular breast imaging features of invasive cancer, including lesion type and intensity, differ by histologic subtype. Direct-conversion molecular breast imaging is less likely to show all foci of ILC compared with IDC.",
keywords = "Breast cancer, Invasive ductal carcinoma, Invasive lobular carcinoma, Molecular breast imaging",
author = "Conners, {Amy Lynn} and Jones, {Katie N.} and Hruska, {Carrie B} and Geske, {Jennifer R.} and Boughey, {Judy C} and Deborah Rhodes",
year = "2015",
month = "9",
day = "1",
doi = "10.2214/AJR.14.13502",
language = "English (US)",
volume = "205",
pages = "W374--W381",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "3",

}

TY - JOUR

T1 - Direct-conversion molecular breast imaging of invasive breast cancer

T2 - Imaging features, extent of invasive disease, and comparison between invasive ductal and lobular histology

AU - Conners, Amy Lynn

AU - Jones, Katie N.

AU - Hruska, Carrie B

AU - Geske, Jennifer R.

AU - Boughey, Judy C

AU - Rhodes, Deborah

PY - 2015/9/1

Y1 - 2015/9/1

N2 - OBJECTIVE. The purposes of this study were to compare the tumor appearance of invasive breast cancer on direct-conversion molecular breast imaging using a standardized lexicon and to determine how often direct-conversion molecular breast imaging identifies all known invasive tumor foci in the breast, and whether this differs for invasive ductal versus lobular histologic profiles. MATERIALS AND METHODS. Patients with prior invasive breast cancer and concurrent direct-conversion molecular breast imaging examinations were retrospectively reviewed. Blinded review of direct-conversion molecular breast imaging examinations was performed by one of two radiologists, according to a validated lexicon. Direct-conversion molecular breast imaging findings were matched with lesions described on the pathology report to exclude benign reasons for direct-conversion molecular breast imaging findings and to document direct-conversion molecular breast imaging-occult tumor foci. Associations between direct-conversion molecular breast imaging findings and tumor histologic profiles were examined using chi-square tests. RESULTS. In 286 patients, 390 invasive tumor foci were present in 294 breasts. A corresponding direct-conversion molecular breast imaging finding was present for 341 of 390 (87%) tumor foci described on the pathology report. Invasive ductal carcinoma (IDC) tumor foci were more likely to be a mass (40% IDC vs 15% invasive lobular carcinoma [ILC]; p <0.001) and to have marked intensity than were ILC foci (63% IDC vs 32% ILC; p <0.001). Direct-conversion molecular breast imaging correctly revealed all pathology-proven foci of invasive disease in 79.8% of cases and was more likely to do so for IDC than for ILC (86.1% vs 56.7%; p <0.0001). Overall, direct-conversion molecular breast imaging showed all known invasive foci in 249 of 286 (87%) patients. CONCLUSION. Direct-conversion molecular breast imaging features of invasive cancer, including lesion type and intensity, differ by histologic subtype. Direct-conversion molecular breast imaging is less likely to show all foci of ILC compared with IDC.

AB - OBJECTIVE. The purposes of this study were to compare the tumor appearance of invasive breast cancer on direct-conversion molecular breast imaging using a standardized lexicon and to determine how often direct-conversion molecular breast imaging identifies all known invasive tumor foci in the breast, and whether this differs for invasive ductal versus lobular histologic profiles. MATERIALS AND METHODS. Patients with prior invasive breast cancer and concurrent direct-conversion molecular breast imaging examinations were retrospectively reviewed. Blinded review of direct-conversion molecular breast imaging examinations was performed by one of two radiologists, according to a validated lexicon. Direct-conversion molecular breast imaging findings were matched with lesions described on the pathology report to exclude benign reasons for direct-conversion molecular breast imaging findings and to document direct-conversion molecular breast imaging-occult tumor foci. Associations between direct-conversion molecular breast imaging findings and tumor histologic profiles were examined using chi-square tests. RESULTS. In 286 patients, 390 invasive tumor foci were present in 294 breasts. A corresponding direct-conversion molecular breast imaging finding was present for 341 of 390 (87%) tumor foci described on the pathology report. Invasive ductal carcinoma (IDC) tumor foci were more likely to be a mass (40% IDC vs 15% invasive lobular carcinoma [ILC]; p <0.001) and to have marked intensity than were ILC foci (63% IDC vs 32% ILC; p <0.001). Direct-conversion molecular breast imaging correctly revealed all pathology-proven foci of invasive disease in 79.8% of cases and was more likely to do so for IDC than for ILC (86.1% vs 56.7%; p <0.0001). Overall, direct-conversion molecular breast imaging showed all known invasive foci in 249 of 286 (87%) patients. CONCLUSION. Direct-conversion molecular breast imaging features of invasive cancer, including lesion type and intensity, differ by histologic subtype. Direct-conversion molecular breast imaging is less likely to show all foci of ILC compared with IDC.

KW - Breast cancer

KW - Invasive ductal carcinoma

KW - Invasive lobular carcinoma

KW - Molecular breast imaging

UR - http://www.scopus.com/inward/record.url?scp=84942590503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942590503&partnerID=8YFLogxK

U2 - 10.2214/AJR.14.13502

DO - 10.2214/AJR.14.13502

M3 - Article

C2 - 26295674

AN - SCOPUS:84942590503

VL - 205

SP - W374-W381

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 3

ER -